mogranin A contained in dense cytoplasmic granules. Through the secretion of neuropeptides NE cells modulate the activity of normal prostate epithelium but are also capable to influence adjacent transformed epithelial cells via paracrine signals, thus stimulating tumor growth and metastatic capacity. In fact, an increased NE cell population in PCa is thought to be associated with a more aggressive disease, whereas a low number of NE cells in tumor tissue have no specific prognostic meaning. Interestingly, both NE and secretory epithelial lineage are derived from a common pluripotent prostate stem cell. A further basic mechanism involved in the progression of PCa is decreased expression of E-cadherin, the main transmembrane adhesion molecule responsible for cell-to-cell interactions and tissue organization in epithelial cells. Through the cytoplasmic domain, it binds b-catenin, which influences cytoskeletal arrangement. As a consequence, loss of E-cadherin function or expression is considered a crucial event in the Tumor Environment Controls the Fate of CSC disruption of cell-cell adhesion and cytoskeletal architecture and in the acquisition of an invasive phenotype in tumor cells. 
In particular, in PCa, lower expression of E-cadherin was associated with more advanced tumor stage and grade. Poorly differentiated prostate tumors also showed higher expression of vimentin, a cytoskeletal component responsible for maintaining cell integrity, and high levels of vimentin correlated with the invasive capacity of prostate cancer cell lines, including DU145. Traditionally, tumors have been considered to be composed of heterogeneous cells with comparable unlimited proliferative and tumorigenic potential. However, it has recently been hypothesized that only rare cells within the tumor, named cancer stem cells, are able to proliferate extensively and are tumorigenic, whereas the majority of cells in PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/22189790 the tumor mass show a variable degree of differentiation and undergo a limited number of divisions. Their contribution to tumor growth and metastatization is considered to be rather limited. Importantly, this model implies the need for a new therapeutic approach specifically purchase Ridaforolimus targeted towards the CSC in the attempt to definitively eradicate the tumor. However, whether tumor aggressiveness is driven by CSC and by what extent this property may be biologically relevant within the naturally occurring tumor mass is still unsettled. As the presence of CSC in PCa and prostate cancer cell lines was recently demonstrated on the basis of the surface antigenic profile CD44+/a2b1hi/CD133+ and CD44+CD242, respectively, in the present study we aimed to evaluate the contribution of CSC to tumor progression. We isolated CD44+CD242 stem-like cancer cells from the androgen-independent prostate cancer cell line DU145 derived from a brain metastasis of human PCa, showed their CSC properties, and investigated their phenotype and behavior with respect to the bulk DU145 cells. Importantly, in this model of prostate cancer we observed that CSC were able to generate highly aggressive tumors in NOD/SCID mice and that this potential was limited by the presence of differentiated DU145 cells with the consequent growth of less aggressive tumors. Consistently, by growing CSC in conditioned medium from DU145 cells in vitro, we unveiled that diffusible factors released from differentiated tumor cells were able to restrain CSC from differentiating into cell populations showing an aggressi
